Association between the endothelial nitric oxide synthase gene Glu298Asp polymorphism and coronary heart disease: A meta-analysis of 39 case-control studies

Molecular Medicine Reports

Volumn 7, Issue 4, 2013, Pages 1310-1318

  Tian, Guo Xiang ^a   Zeng, Xian Tao ^b   Wang, Xiao Bing ^a   Zhang, Ling ^a   Zhang, Wei ^a   Wei, Wan Lin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Coronary heart disease; Endothelial nitric oxide synthase; Meta analysis; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ARTICLE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS;

CASE-CONTROL STUDIES; CORONARY DISEASE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84875270669     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1301     Document Type: Article

References (57)

1. Negi S and Anand A: Atherosclerotic coronary heart disease-epidemiology, classification and management. Cardiovasc Hematol Disord Drug Targets 10: 257-261, 2010.
2. Murray CJ and Lopez AD: Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 349: 1269-1276, 1997.
3. Rosamond W, Flegal K, Friday G, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics -2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115: e69-e171, 2007.
4. Mi X, Eskridge KM, George V and Wang D: Structural equation modeling of gene-environment interactions in coronary heart disease. Ann Hum Genet 75: 255-265, 2011.
5. Kullo IJ and Ding K: Mechanisms of disease: The genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med 4: 558-569, 2007.
6. Marsden PA, Heng HH, Scherer SW, et al: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268: 17478-17488, 1993.
7. Shimasaki Y, Yasue H, Yoshimura M, et al: Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31: 1506-1510, 1998.
8. Li J, Wu X, Li X, Feng G, He L and Shi Y: The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis. Cardiology 116: 271-278, 2010.
9. Zhang K, Bai P, Shi S, et al: The G894T polymorphism on endothelial nitric oxide synthase gene is associated with increased coronary heart disease among Asia population: evidence from a Meta analysis. Thromb Res 130: 192-197, 2012.
10. Moher D, Liberati A, Tetzlaff J and Altman DG; PRISM Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097, 2009.
11. Borenstein M, Hedges L, Higgins J, Rothstein H and Englewood NJ: Comprehensive meta-analysis: A computer program for meta-analysis. Biostat Inc: 2007. [Computer software].
12. Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002.
13. Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557-560, 2003.
14. Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
15. Duval S and Tweedie R: Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463, 2000.
16. Yoshimura M, Yasue H, Nakayama M, et al: A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103: 65-69, 1998.
17. Cai H, Wilcken DE and Wang XL: The Glu→298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med (Berl) 77: 511-514, 1999.
18. Hingorani AD, Liang CF, Fatibene J, et al: A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100: 1515-1520, 1999.
19. Poirier O, Mao C, Mallet C, et al: Polymorphisms of the endothelial nitric oxide synthase gene -no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 29: 284-290, 1999.
20. Yoon Y, Song J, Hong SH and Kim JQ: Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 46: 1626-1630, 2000.
21. Yoshimura M, Yasue H, Nakayama M, et al: Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786->C and missense Glu298Asp variants. J Investig Med 48: 367-374, 2000.
22. Granath B, Taylor RR, van Bockxmeer FM and Mamotte CD: Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk 8: 235-241, 2001.
23. Wang CL, Hsu LA, Ko YS, Ko YL and Lee YH: Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc 100: 736-740, 2001.
24. Colombo MG, Andreassi MG, Paradossi U, et al: Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87: 525-528, 2002.
25. Wei D, Shan J, Chen Z and Shi Y: The G894T mutation of the endothelial nitric oxide synthase gene is associated with coronary atherosclerotic heart disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19: 471-474, 2002 (In Chinese).
26. Chang K, Baek SH, Seung KB, et al: The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis 14: 293-299, 2003.
27. Colombo MG, Paradossi U, Andreassi MG, et al: Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49: 389-395, 2003.
28. Afrasyap L and Ozturk G: NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochim Biophys Sin (Shanghai) 36: 661-666, 2004.
29. Agema WR, de Maat MP, Zwinderman AH, et al: An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men. Clin Sci (Lond) 107: 255-261, 2004.
30. Cam SF, Sekuri C, Tengiz I, et al: The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res 116: 287-292, 2005.
31. Jaramillo PC, Muñoz MA, Lanas MC, Lanas ZF and Salazar LA: Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 371: 102-106, 2006.
32. Kerkeni M, Addad F, Chauffert M, et al: Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 52: 53-58, 2006.
33. Ji XW, Zhang AY and Guan LX: Association between angiotensin-converting enzyme and endothelial nitric oxide synthase gene polymorphism and risk of coronary artery disease. Zhonghua Xin Xue Guan Bing Za Zhi 35: 1024-1028, 2007 (In Chinese).
34. Kim IJ, Bae J, Lim SW, et al: Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thromb Res 119: 579-585, 2007.
35. Wang ZL, Zhao YQ, Liao JD, et al: Association of endothelial nitric oxide synthase gene polymorphism with level of uric acid in serum for acute coronary syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19: 652-656, 2007 (In Chinese).
36. Mathew J, Narayanan P, Sundaram R, et al: Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population. Indian Heart J 60: 223-227, 2008.
37. Tamemoto H, Ishikawa SE and Kawakami M: Association of the Glu298Asp polymorphism of the eNOS gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract 80: 275-279, 2008.
38. Vasilakou M, Votteas V, Kasparian C, et al: Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population. Acta Cardiol 63: 609-614, 2008.
39. Zakrzewski-Jakubiak M, de Denus S, Dubé MP, Bélanger F, White M and Turgeon J: Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure. Br J Clin Pharmacol 65: 742-751, 2008.
40. Alp E, Menevse S, Tulmac M, et al: Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population. DNA Cell Biol 28: 343-350, 2009.
41. Alkharfy KM, Al-Daghri NM, Al-Attas OS, Alokail MS, Draz HM and Hussain T: Endothelial nitric oxide synthase gene polymorphisms (894G > T and -786T > C) and risk of coronary artery disease in a Saudi population. Arch Med Res 41: 134-141, 2010.
42. Angeline T, Isabel W and Tsongalis GJ: Endothelial nitric oxide gene polymorphisms, nitric oxide production and coronary artery disease risk in a South Indian population. Exp Mol Pathol 89: 205-208, 2010.
43. Bor-Kucukatay M, Demir S, Akbay R, Dursunoglu D, Akdag B and Semiz E: Relationship between hemorheology and Glu(298)Asp polymorphism of endothelial nitric oxide synthase gene in patients with coronary artery disease. Mol Biol Rep 37: 171-178, 2010.
44. Isordia-Salas I, Leaños-Miranda A and Borrayo-Sánchez G: The Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta 411: 553-557, 2010.
45. Salimi S, Firoozrai M, Zand H, et al: Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease. Ann Saudi Med 30: 33-37, 2010.
46. Velloso MW, Pereira SB, Gouveia L, et al: Endothelial nitric oxide synthase Glu298Asp gene polymorphism in a multi-ethnical population with heart failure and controls. Nitric Oxide 22: 220-225, 2010.
47. Motawi T, Shaker O, Taha M, Sedrak H and Nabil M: Endothelial nitric oxide synthase and angiotensinogen gene polymorphism in coronary artery diseases in Egypt. Angiology 62: 191-197, 2011.
48. Saini V, Bhatnagar MK and Bhattacharjee J: Association of endothelial dysfunction with endothelin, nitric oxide and eNOS Glu298Asp gene polymorphism in coronary artery disease. Dis Markers 31: 215-222, 2011.
49. da Costa Escobar Piccoli J, Manfredini V, Hamester FI, et al: Interaction between endothelial nitric oxide synthase gene polymorphisms (-786T>C, 894G>T and intron 4 a/b) and cardiovascular risk factors in acute coronary syndromes. Arch Med Res 43: 205-211, 2012.
50. Gad MZ, Abdel Rahman MF, Hashad IM, Abdel-Maksoud SM, Farag NM and Abou-Aisha K: Endothelial nitric oxide synthase (G894T) gene polymorphism in a random sample of the Egyptian population: comparison with myocardial infarction patients. Genet Test Mol Biomarkers 16: 695-700, 2012.
51. Rahimi Z and Nourozi-Rad R: Association of endothelial nitric oxide synthase gene variant (G894T) with coronary artery disease in Western Iran. Angiology 63: 131-137, 2012.
52. Rai H, Fitt J, Sharma AK, et al: Lack of association between Glu298Asp polymorphism and coronary artery disease in North Indians. Mol Biol Rep 39: 5995-6000, 2012.
53. Superko HR, Roberts R, Agatston A, et al: Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises. Curr Atheroscler Rep 13: 396-404, 2011.
54. Devuyst O: Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide? J Nephrol 16: 449-452, 2003.
55. Takaoka M. NOS gene polymorphism. Nihon Rinsho 62: 103-109, 2004 (In Japanese).
56. León-Velarde F and Mejía O: Gene expression in chronic high altitude diseases. High Alt Med Biol 9: 130-139, 2008.
57. Su MT, Lin SH and Chen YC: Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update 17: 803-812, 2011.